194 related articles for article (PubMed ID: 15360048)
1. Differential effects of toremifene on doxorubicin, vinblastine and Tc-99m-sestamibi in P-glycoprotein-expressing breast and head and neck cancer cell lines.
Mubashar M; Harrington KJ; Chaudhary KS; Lalani el-N; Stamp GW; Peters AM
Acta Oncol; 2004; 43(5):443-52. PubMed ID: 15360048
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer.
Mubashar M; Harrington KJ; Chaudhary KS; Lalani el-N; Stamp GW; Sinnett D; Glass DM; Peters AM
J Nucl Med; 2002 Apr; 43(4):519-25. PubMed ID: 11937596
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro multitracer analyses of P-glycoprotein expression-related multidrug resistance.
Márián T; Szabó G; Goda K; Nagy H; Szincsák N; Juhász I; Galuska L; Balkay L; Mikecz P; Trón L; Krasznai Z
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1147-54. PubMed ID: 12830325
[TBL] [Abstract][Full Text] [Related]
4. 99Tcm-sestamibi imaging of inhibition of the multidrug resistance transporter in a mouse xenograft model of human breast cancer.
Muzzammil T; Ballinger JR; Moore MJ
Nucl Med Commun; 1999 Feb; 20(2):115-22. PubMed ID: 10088159
[TBL] [Abstract][Full Text] [Related]
5. Comparison of (99m)Tc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function.
Muzzammil T; Moore MJ; Hedley D; Ballinger JR
Br J Cancer; 2001 Feb; 84(3):367-73. PubMed ID: 11161402
[TBL] [Abstract][Full Text] [Related]
6. In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients.
Vecchio SD; Ciarmiello A; Potena MI; Carriero MV; Mainolfi C; Botti G; Thomas R; Cerra M; D'Aiuto G; Tsuruo T; Salvatore M
Eur J Nucl Med; 1997 Feb; 24(2):150-9. PubMed ID: 9021112
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m sestamibi uptake in human breast carcinoma cell lines displaying glutathione-associated drug-resistance.
Kabasakal L; Ozker K; Hayward M; Akansel G; Griffith O; Isitman AT; Hellman R; Collier D
Eur J Nucl Med; 1996 May; 23(5):568-70. PubMed ID: 8698063
[TBL] [Abstract][Full Text] [Related]
8. 99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice.
Liu Z; Stevenson GD; Barrett HH; Kastis GA; Bettan M; Furenlid LR; Wilson DW; Woolfenden JM; Pak KY
Nucl Med Commun; 2004 Jul; 25(7):711-20. PubMed ID: 15208499
[TBL] [Abstract][Full Text] [Related]
9. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.
Piwnica-Worms D; Rao VV; Kronauge JF; Croop JM
Biochemistry; 1995 Sep; 34(38):12210-20. PubMed ID: 7547962
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the in vitro and in vivo properties of a (99m)Tc-labeled inhibitor of the multidrug resistant gene product P-glycoprotein.
Bergmann R; Brust P; Scheunemann M; Pietzsch HJ; Seifert S; Roux F; Johannsen B
Nucl Med Biol; 2000 Feb; 27(2):135-41. PubMed ID: 10773542
[TBL] [Abstract][Full Text] [Related]
11. Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin.
Liu Z; Stevenson GD; Barrett HH; Furenlid LR; Wilson DW; Kastis GA; Bettan M; Woolfenden JM
Nucl Med Biol; 2005 Aug; 32(6):573-83. PubMed ID: 16026704
[TBL] [Abstract][Full Text] [Related]
12. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin.
Chen WS; Luker KE; Dahlheimer JL; Pica CM; Luker GD; Piwnica-Worms D
Biochem Pharmacol; 2000 Aug; 60(3):413-26. PubMed ID: 10856437
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging.
Tatsumi M; Tsuruo T; Nishimura T
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):288-94. PubMed ID: 12002701
[TBL] [Abstract][Full Text] [Related]
14. Functional imaging of multidrug resistance in an orthotopic model of osteosarcoma using 99mTc-sestamibi.
Gomes CM; Welling M; Que I; Henriquez NV; van der Pluijm G; Romeo S; Abrunhosa AJ; Botelho MF; Hogendoorn PC; Pauwels EK; Cleton-Jansen AM
Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1793-803. PubMed ID: 17541583
[TBL] [Abstract][Full Text] [Related]
15. 99Tcm-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant.
Ballinger JR; Hua HA; Berry BW; Firby P; Boxen I
Nucl Med Commun; 1995 Apr; 16(4):253-7. PubMed ID: 7624105
[TBL] [Abstract][Full Text] [Related]
16. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
Moretti JL; Duran Cordobes M; Starzec A; de Beco V; Vergote J; Benazzouz F; Boissier B; Cohen H; Safi N; Piperno-Neumann S; Kouyoumdjian JC
J Nucl Med; 1998 Jul; 39(7):1214-8. PubMed ID: 9669397
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression.
Cordobes MD; Starzec A; Delmon-Moingeon L; Blanchot C; Kouyoumdjian JC; Prévost G; Caglar M; Moretti JL
J Nucl Med; 1996 Feb; 37(2):286-9. PubMed ID: 8667063
[TBL] [Abstract][Full Text] [Related]
18. Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576.
Agrawal M; Abraham J; Balis FM; Edgerly M; Stein WD; Bates S; Fojo T; Chen CC
Clin Cancer Res; 2003 Feb; 9(2):650-6. PubMed ID: 12576431
[TBL] [Abstract][Full Text] [Related]
19. Novel technetium (III)-Q complexes for functional imaging of multidrug resistance (MDR1) P-glycoprotein.
Crankshaw CL; Marmion M; Luker GD; Rao V; Dahlheimer J; Burleigh BD; Webb E; Deutsch KF; Piwnica-Worms D
J Nucl Med; 1998 Jan; 39(1):77-86. PubMed ID: 9443741
[TBL] [Abstract][Full Text] [Related]
20. The multidrug resistance of in vitro tumor cell lines derived from human breast carcinoma MCF-7 does not influence pentavalent technetium-99m-dimercaptosuccinic Acid uptake.
Denoyer D; Perek N; Le Jeune N; Frère D; Dubois F
Cancer Biother Radiopharm; 2003 Oct; 18(5):791-801. PubMed ID: 14629827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
